# Safety and Efficacy of Adalimumab Therapy for Treatment of Behcet's Disease-related Uveitis in Sohag University Hospital

> **NCT05683626** · — · UNKNOWN · sponsor: **Sohag University** · enrollment: 40 (estimated)

## Conditions studied

- Uveitis

## Interventions

- **DRUG:** Humira

## Key facts

- **NCT ID:** NCT05683626
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-15
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05683626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05683626, "Safety and Efficacy of Adalimumab Therapy for Treatment of Behcet's Disease-related Uveitis in Sohag University Hospital". Retrieved via MORVS 2026-10-16 from https://api.morvs.ai/clinical/NCT05683626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*